MedTrace Logo

Effects of Quinoa Consumption on Markers of Cardiovascular Risk and Gastrointestinal Health

NCT03036618 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-01-30

No results posted yet for this study

Summary

Quinoa is possible alternative to wheat, corn and rice due to its high nutritional value and possible properties against cardiovascular diseases and for improving gut health. There are some animal studies to suggest that some important class of compounds like fibre, antioxidants and protein, found naturally in quinoa, have beneficial effects against markers of cardiovascular diseases. However, the effects of quinoa on humans has rarely been investigated. This study will investigate the effects of daily consumption of quinoa for four weeks on markers of cardiovascular risk, including blood cholesterol and resting blood pressure, and on gut health in a randomised cross-over study design.

Conditions

  • Change in Fasting Plasma LDL-cholesterol Concentration After the Consumption of Quinoa

Interventions

DIETARY_SUPPLEMENT

Quinoa

Test wheat bread roll (approximately 160g weight) delivering 20 g quinoa consumed per day.

DIETARY_SUPPLEMENT

Wheat

Test wheat bread roll (approximately 160g weight) without quinoa.

Sponsors & Collaborators

  • Newcastle University

    lead OTHER

Principal Investigators

  • Chris Seal, Professor · Newcastle University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-02-28
Completion
2018-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03036618 on ClinicalTrials.gov